There is solid evidence that the prognosis of AMI is associated with various factors, including dyslipidemia, smoking status, hypertension, diabetes mellitus, age, male gender, and plasma levels of B-type natriuretic peptide (BNP) and matrix metalloproteinase-9 (MMP-9) [4–7]. This evidence concerns the gene MMP9 and metabolic syndrome.